GSK Fair Value
GL
The fair market value of GLAXF stock is 1647.87 USD. Relative to the market price of 17.615 USD GSK is undervalued by 9254.9%
Eyestock's quantitative valuation approach is based on the method of estimating historical multipliers. To determine whether a stock is undervalued, we compare its current price to our estimated of fair value. The more undervalued a stock is, the more investment is profitable.
Fair Relative Value
GSK Valuation
Current GLAXF share ticker price is 17.615 USD.
The fair value level of 1647.87 USD can be considered as an effective entry point for long-term investors to start investing in GLAXF stock. For a more in-depth assessment, we provide a minimum value that can be used to increase a stock position and a maximum one that can be used to reduce it.
Price chart is not available
Current market price
Current price is 9255% lower its fair value
Current price is 2705% lower its minimum value
Current price is 13169% lower its maximum value
Market price:
GLAXF stock is overvalued
It means the current price may concern as a Risky Entry Point
GSK plc Stock Valuation Calculator
How do we value a stock?
As fair value, we use the product of the median Price-to-earnings ratios at the end of each reporting period for the last 5 years and earnings per share for the last 12 months. By analogy with the fair value, we calculate the maximum and minimum ones using the corresponding P/E extremums.
1
Maximum P/E over 5 years
18.76
2
Median P/E over 5 years
13.23
3
Minimum P/E over 5 years
3.97
4
Earning per share (last 12 months)
97.79 GBP
Maximum value
1
x
4
=
2 337.29 USD
Fair value
2
x
4
=
1 647.87 USD
Minimum value
3
x
4
=
494.11 USD
GSK plc price metrics
-4.47
Annual return (geometric mean)
22.42
Risk (standard deviation) of returns
β
0.55
Beta (volatility compared to market)